Investor profile
Surveyor Capital has backed 4 European tech companies across 4 funding rounds between 2021 and 2023, joining rounds totalling €515M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Compass Pathways | UK | 1 | €261M |
| Vectivbio | Switzerland | 1 | €127M |
| Ambagon Therapeutics | Netherlands | 1 | €75M |
| Anjarium Biosciences | Switzerland | 1 | €51M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Compass Pathways | Other | €261M | 2023-08 |
| Vectivbio | Other | €127M | 2022-10 |
| Ambagon Therapeutics | Series A | €75M | 2022-01 |
| Anjarium Biosciences |
| Series A |
| €51M |
| 2021-09 |
